• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGFβ 通路限制 WNT 和 MAPK 通路激活后的去分化,以抑制肠道肿瘤发生。

TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis.

机构信息

Wnt Signaling and Colorectal Cancer Group, Cancer Research UK Beatson Institute, Garscube Estate, Glasgow G61 1BD, UK.

Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt 60596 Germany.

出版信息

Cell Death Differ. 2017 Oct;24(10):1681-1693. doi: 10.1038/cdd.2017.92. Epub 2017 Jun 16.

DOI:10.1038/cdd.2017.92
PMID:28622298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5596428/
Abstract

Recent studies have suggested increased plasticity of differentiated cells within the intestine to act both as intestinal stem cells (ISCs) and tumour-initiating cells. However, little is known of the processes that regulate this plasticity. Our previous work has shown that activating mutations of Kras or the NF-κB pathway can drive dedifferentiation of intestinal cells lacking Apc. To investigate this process further, we profiled both cells undergoing dedifferentiation in vitro and tumours generated from these cells in vivo by gene expression analysis. Remarkably, no clear differences were observed in the tumours; however, during dedifferentiation in vitro we found a marked upregulation of TGFβ signalling, a pathway commonly mutated in colorectal cancer (CRC). Genetic inactivation of TGFβ type 1 receptor (Tgfbr1/Alk5) enhanced the ability of Kras mutation to drive dedifferentiation and markedly accelerated tumourigenesis. Mechanistically this is associated with a marked activation of MAPK signalling. Tumourigenesis from differentiated compartments is potently inhibited by MEK inhibition. Taken together, we show that tumours arising in differentiated compartments will be exposed to different suppressive signals, for example, TGFβ and blockade of these makes tumourigenesis more efficient from this compartment.

摘要

最近的研究表明,肠道中分化细胞的可塑性增加,既能作为肠干细胞(ISCs),也能作为肿瘤起始细胞。然而,人们对调节这种可塑性的过程知之甚少。我们之前的工作表明,Kras 或 NF-κB 通路的激活突变可以驱动缺乏 APC 的肠细胞去分化。为了进一步研究这个过程,我们通过基因表达分析对体外经历去分化的细胞和体内由这些细胞产生的肿瘤进行了分析。值得注意的是,在肿瘤中没有观察到明显的差异;然而,在体外去分化过程中,我们发现 TGFβ 信号通路显著上调,该通路在结直肠癌(CRC)中经常发生突变。TGFβ 型 1 受体(Tgfbr1/Alk5)的遗传失活增强了 Kras 突变驱动去分化的能力,并显著加速了肿瘤发生。从机制上讲,这与 MAPK 信号的显著激活有关。MEK 抑制强烈抑制来自分化区室的肿瘤发生。总之,我们表明,在分化区室中发生的肿瘤将暴露于不同的抑制信号,例如 TGFβ,阻断这些信号会使肿瘤发生从该区室更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/00e78a78e8d5/cdd201792f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/3471f31773f8/cdd201792f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/42ab57d49459/cdd201792f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/e05d7be6e131/cdd201792f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/b696bdf6fd12/cdd201792f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/fe702e3979f6/cdd201792f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/f97053057db3/cdd201792f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/00e78a78e8d5/cdd201792f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/3471f31773f8/cdd201792f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/42ab57d49459/cdd201792f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/e05d7be6e131/cdd201792f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/b696bdf6fd12/cdd201792f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/fe702e3979f6/cdd201792f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/f97053057db3/cdd201792f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b6f/5596428/00e78a78e8d5/cdd201792f7.jpg

相似文献

1
TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis.TGFβ 通路限制 WNT 和 MAPK 通路激活后的去分化,以抑制肠道肿瘤发生。
Cell Death Differ. 2017 Oct;24(10):1681-1693. doi: 10.1038/cdd.2017.92. Epub 2017 Jun 16.
2
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.突变型K-ras(Asp12)在Apc(Min)小鼠中促进肿瘤发生的作用在大肠比小肠更明显,且K-ras和Wnt信号通路之间存在协同效应。
Int J Exp Pathol. 2009 Oct;90(5):558-74. doi: 10.1111/j.1365-2613.2009.00667.x.
3
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.TRIB3 通过与β-catenin 和 TCF4 相互作用来增加结直肠癌细胞干细胞的干细胞特征和肿瘤发生。
Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.
4
Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.突变型 K-ras 促进致癌物诱导的小鼠结直肠肿瘤发生,但不改变肿瘤染色体稳定性。
J Pathol. 2011 Feb;223(3):390-9. doi: 10.1002/path.2790. Epub 2010 Nov 11.
5
RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation.RAF1-MEK/ERK 通路依赖性 ARL4C 表达促进成釉细胞瘤细胞增殖和破骨细胞形成。
J Pathol. 2022 Jan;256(1):119-133. doi: 10.1002/path.5814. Epub 2021 Nov 16.
6
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.在突变型 KRAS 的结直肠癌细胞中,SLC25A22 介导的谷氨酰胺分解作用降低 DNA 去甲基化以增加 WNT 信号、干性和耐药性。
Gastroenterology. 2020 Dec;159(6):2163-2180.e6. doi: 10.1053/j.gastro.2020.08.016. Epub 2020 Aug 16.
7
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.上皮细胞 TGFβ 通过与生长因子信号通路的相互作用,避免了细胞凋亡,并驱动具有侵袭性特征的肠道肿瘤发生。
Nat Commun. 2022 Dec 7;13(1):7551. doi: 10.1038/s41467-022-35134-3.
8
KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.KRAS 突变响应的 miR-139-5p 抑制结直肠癌细胞进展,受 Wnt 信号抑制。
Theranostics. 2020 Jun 5;10(16):7335-7350. doi: 10.7150/thno.45971. eCollection 2020.
9
BRAF drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation.BRAF 驱动小肠和结肠类器官去分化,并与突变型 p53 和 APC 缺失协同转化。
Oncogene. 2020 Sep;39(38):6053-6070. doi: 10.1038/s41388-020-01414-9. Epub 2020 Aug 13.
10
TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function.转化生长因子β(TGFβ)激活丝裂原活化蛋白激酶/细胞外信号调节激酶(MEK/ERK)以差异性调节良性和恶性胰腺细胞功能。
Oncogene. 2017 Jul 27;36(30):4336-4348. doi: 10.1038/onc.2016.500. Epub 2017 Apr 3.

引用本文的文献

1
Functional maturation of preterm intestinal epithelium through CFTR activation.通过囊性纤维化跨膜传导调节因子(CFTR)激活实现早产肠道上皮的功能成熟。
Commun Biol. 2025 Apr 2;8(1):540. doi: 10.1038/s42003-025-07944-w.
2
Exploring the Role of the TGF-β Signaling Pathway in Colorectal Precancerous Polyps Biochemical Genetics.探索转化生长因子-β信号通路在结直肠癌前息肉生化遗传学中的作用。
Biochem Genet. 2025 Apr;63(2):1116-1148. doi: 10.1007/s10528-024-10988-y. Epub 2024 Dec 5.
3
Therapeutic targeting of TGF-β in lung cancer.肺癌中转化生长因子-β的治疗靶向作用

本文引用的文献

1
Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research.用于结肠癌研究的可诱导结肠特异性Cre酶小鼠品系的构建。
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11859-11864. doi: 10.1073/pnas.1614057113. Epub 2016 Oct 5.
2
Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.转化生长因子β(TGFβ)信号通路的缺失会促进结肠癌进展及肿瘤相关炎症。
Oncotarget. 2017 Jan 17;8(3):3826-3839. doi: 10.18632/oncotarget.9830.
3
ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas.
FEBS J. 2025 Apr;292(7):1520-1557. doi: 10.1111/febs.17234. Epub 2024 Jul 31.
4
Critical role of thrombospondin-1 in promoting intestinal mucosal wound repair.血小板反应蛋白-1 在促进肠道黏膜伤口修复中起关键作用。
JCI Insight. 2024 Jul 30;9(17):e180608. doi: 10.1172/jci.insight.180608.
5
Colonic Tuft Cells: The Less-Recognized Therapeutic Targets in Inflammatory Bowel Disease and Colorectal Cancer.结肠微绒毛细胞:炎症性肠病和结直肠癌中较少被认识的治疗靶点。
Int J Mol Sci. 2024 Jun 5;25(11):6209. doi: 10.3390/ijms25116209.
6
Drosophila activins adapt gut size to food intake and promote regenerative growth.果蝇激活素适应食物摄入调节肠道大小并促进再生生长。
Nat Commun. 2024 Jan 4;15(1):273. doi: 10.1038/s41467-023-44553-9.
7
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.KRAS 等位基因失衡驱动结直肠癌体内肿瘤起始,但抑制转移。
Nat Commun. 2024 Jan 2;15(1):100. doi: 10.1038/s41467-023-44342-4.
8
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.β-连环蛋白驱动结直肠癌中丁酸酯蛋白样分子丢失和 γδ T 细胞排斥。
Cancer Immunol Res. 2023 Aug 3;11(8):1137-1155. doi: 10.1158/2326-6066.CIR-22-0644.
9
Ecological niches for colorectal cancer stem cell survival and thrival.结直肠癌干细胞存活和增殖的生态位
Front Oncol. 2023 Apr 13;13:1135364. doi: 10.3389/fonc.2023.1135364. eCollection 2023.
10
Frizzled 7 modulates goblet and Paneth cell fate, and maintains homeostasis in mouse intestine.卷曲蛋白 7 调节杯状细胞和潘氏细胞的命运,并维持小鼠肠道内的稳态。
Development. 2023 Feb 15;150(4). doi: 10.1242/dev.200932. Epub 2023 Feb 14.
ETS家族转录调节因子驱动鳞状细胞癌中的染色质动力学和恶性肿瘤发展。
Elife. 2015 Nov 21;4:e10870. doi: 10.7554/eLife.10870.
4
The consensus molecular subtypes of colorectal cancer.结直肠癌的共识分子亚型
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
5
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.基质基因表达定义了结直肠癌的预后不良亚型。
Nat Genet. 2015 Apr;47(4):320-9. doi: 10.1038/ng.3225. Epub 2015 Feb 23.
6
Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.异常的上皮性GREM1表达从干细胞龛外的细胞引发结肠肿瘤发生。
Nat Med. 2015 Jan;21(1):62-70. doi: 10.1038/nm.3750. Epub 2014 Dec 1.
7
Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β.肠道腺瘤中的致癌突变调节由转化生长因子-β诱导的Bim介导的细胞凋亡。
Proc Natl Acad Sci U S A. 2014 May 27;111(21):E2229-36. doi: 10.1073/pnas.1406444111. Epub 2014 May 13.
8
Long-lived intestinal tuft cells serve as colon cancer-initiating cells.长寿的肠簇细胞作为结肠癌起始细胞。
J Clin Invest. 2014 Mar;124(3):1283-95. doi: 10.1172/JCI73434.
9
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation.ROS 产生和 NF-κB 的激活由 RAC1 触发,促进了 WNT 驱动的肠干细胞增殖和结直肠肿瘤的发生。
Cell Stem Cell. 2013 Jun 6;12(6):761-73. doi: 10.1016/j.stem.2013.04.006. Epub 2013 May 9.
10
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.肠肿瘤发生由去分化和获得干细胞样特性引发。
Cell. 2013 Jan 17;152(1-2):25-38. doi: 10.1016/j.cell.2012.12.012. Epub 2012 Dec 27.